 "coronavirus")
The US won’t agree to waive intellectual-property protections for Covid-19 treatments and tests this year -- aligning with developed-nation peers and damaging prospects for a World Trade Organization accord aimed at boosting global access to life-saving medicines.
An official from the Biden administration told Bloomberg News on Monday that it needs more information, and plans to ask the US International Trade Commission to launch an investigation into the matter. The official declined to be identified because the information was private.
Such investigations can take nine months to a year to complete -- which means delays for a deal that aims
